Canada· CA-DIN-02242810
SCOPOLAMINE HYDROBROMIDE INJECTION
A scopolamine product containing scopolamine hydrobromide, registered in Canada by OMEGA LABORATORIES LIMITED. The same ATC class is registered in 3 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Scopolamine is registered in 3 of 19 countries.
Countries holding a registration under ATC N05CM05 (scopolamine), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 2 of them publish a price we can compare per daily dose
Scopolamine · ATC N05CM05
3 / 19 countries
- Canada
- Norwayprice
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- SCOPOLAMINE HYDROBROMIDE
- Manufacturer
- OMEGA LABORATORIES LIMITED
- Country
- Canada (CA)
- ATC code
- N05CM05
- ATC class
- Scopolamine
- Defined daily dose
- 0.9 mg, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
335 interactions on record for scopolamine.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Scopolamine · interactions on record
335 records
- 7 severe
- 197 moderate
- 17 minor
- 114 info
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- DextropropoxypheneN02AC04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Scopolamine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomHyoscine 1mg/72hours transdermal patchesImported
- United StatesscopolamineActavis Pharma, Inc.
- FranceBROMHYDRATE DE SCOPOLAMINE RENAUDIN 0,025 %, solution injectableLABORATOIRE RENAUDIN
- BelgiumBromhydrate de Scopolamine 0,25 mg/mlLaboratoires Sterop
- FinlandOftan-ScopolaminSanten Oy
- IrelandHyoscine Hydrobromide Martindale Pharma 600 micrograms/ml Solution for InjectionEthypharm
- GermanyBoro-Scopol NOmnivision Gmbh
- NorwayScopodermBaxter Medical AB
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Belgium · Scopolamine Hbr Sterop
- Germany · Boro-Scopol N, Scopoderm Tts
- Denmark · Scopoderm
- Spain · Escopolamina B. Braun
- Finland · Scopoderm
- France · Bromhydrate De Scopolamine Renaudin, Scopoderm Tts
- United Kingdom (Northern Ireland) · Hyoscine Hydrobromide Wockhardt Uk, Hyoscine Martindale Pharma
- Ireland · Hyoscine Injection Bp Ethypharm, Kwells
- Iceland · Scopoderm
- Luxembourg · Scopoderm Tts
- Malta · Kwells
- Netherlands · Scopoderm
- Norway · Scopoderm
- Sweden · Scopoderm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c5432bac-93b1-4b5a-8d23-75a4b1ec8964 GET /v1/drugs/c5432bac-93b1-4b5a-8d23-75a4b1ec8964?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02242810",
"form": "LIQUID",
"class": "Human",
"routes": [
"INTRAMUSCULAR",
"INTRAVENOUS",
"SUBCUTANEOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "N05CM05",
"schedule": [
"Ethical"
],
"drug_code": "66635",
"strengths": [
"0.4 MG"
],
"ahfs_class": null,
"substances": [
"SCOPOLAMINE HYDROBROMIDE"
],
"product_categorization": null
}See everything about scopolamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.